Truth Social post of March 28, 2026

PostStatementPublished 03/28Open the original

Summary

President Trump shares an article saying the TrumpRx website sees steady growth in prescription offerings.

By industry

Healthcare & Drug Pricing1 trading day+0.9%p15 stocks5 trading days+0.5%p15 stocks20 trading days−10.1%p15 stocks

Day by day after the announcement

Healthcare & Drug Pricing stocks and the S&P 500 after the announcement, cumulative %
Day	Healthcare & Drug Pricing stocks	S&P 500
26/03/27	0.0%	0.0%
26/03/30	+0.5%	−0.5%
26/03/31	+2.5%	+2.8%
26/04/01	+3.5%	+3.5%
26/04/02	+3.3%	+3.6%
26/04/06	+4.5%	+4.0%
26/04/07	+3.5%	+6.4%
26/04/08	+5.2%	+6.6%
26/04/09	+5.4%	+7.3%
26/04/10	+4.1%	+7.3%
26/04/13	+4.1%	+8.4%
26/04/14	+4.2%	+9.7%
26/04/15	+3.2%	+10.5%
26/04/16	+3.8%	+10.8%
26/04/17	+5.0%	+12.1%
26/04/20	+3.9%	+12.1%
26/04/21	+3.4%	+11.6%
26/04/22	+2.9%	+12.2%
26/04/23	+4.3%	+12.0%
26/04/24	+3.0%	+12.7%
26/04/27	+3.0%	+13.1%

Korean stocks in these industries

Samsung Biologics 207940
Celltrion 068270
SK Biopharmaceuticals 326030

Trades in these industries around the announcement

Members' and insiders' trades in the industries' stocks, 30 days before to 30 days after.

Steven H. CollisDirector
BuyElevance Health
Buy
Elevance Health
ELV
$869.5K
3,000 sh
$869.5K
Filed 03/06
Traded 03/05
Alan ArmstrongSenator · Republican · OK
Full saleAmgen
Full sale
Amgen
AMGN
$15K–$50K
Self
$15K–$50K
Reported 07/21
Traded 03/27
Alan ArmstrongSenator · Republican · OK
BuyUnitedhealth Group
Buy
Unitedhealth Group
UNH
$15K–$50K
Self
$15K–$50K
Reported 07/21
Traded 03/27
Alan ArmstrongSenator · Republican · OK
Full salePfizer
Full sale
Pfizer
PFE
$50K–$100K
Self
$50K–$100K
Reported 07/21
Traded 03/24
Esteban SantosEVP, Operations
SellAmgen
Sell
Amgen
AMGN
$11.6M
30,501 sh
$11.6M
Filed 03/02
Traded 02/26
Alan ArmstrongSenator · Republican · OK
BuyJohnson & Johnson
Buy
Johnson & Johnson
JNJ
$15K–$50K
Self
$15K–$50K
Reported 07/21
Traded 03/27
Alan ArmstrongSenator · Republican · OK
Full saleMerck
Full sale
Merck
MRK
$15K–$50K
Self
$15K–$50K
Reported 07/21
Traded 03/27
Alan ArmstrongSenator · Republican · OK
BuyAbbVie
Buy
AbbVie
ABBV
$15K–$50K
Self
$15K–$50K
Reported 07/21
Traded 03/27
Esteban SantosEVP, Operations
SellAmgen
Sell
Amgen
AMGN
$9.2M
24,291 sh
$9.2M
Filed 03/02
Traded 02/26
Alan ArmstrongSenator · Republican · OK
BuyElevance Health
Buy
Elevance Health
ELV
$1K–$15K
Self
$1K–$15K
Reported 07/21
Traded 03/27
Alan ArmstrongSenator · Republican · OK
BuyMcKesson
Buy
McKesson
MCK
$1K–$15K
Self
$1K–$15K
Reported 07/21
Traded 03/27
Alan ArmstrongSenator · Republican · OK
BuyJohnson & Johnson
Buy
Johnson & Johnson
JNJ
$1K–$15K
Self
$1K–$15K
Reported 07/21
Traded 03/30
Alan ArmstrongSenator · Republican · OK
Full saleELI Lilly
Full sale
ELI Lilly
LLY
$1K–$15K
Self
$1K–$15K
Reported 07/21
Traded 03/27
Alan ArmstrongSenator · Republican · OK
BuyGilead Sciences
Buy
Gilead Sciences
GILD
$1K–$15K
Self
$1K–$15K
Reported 07/21
Traded 03/27
Patrick Hugh ConwayCEO, Optum
SellUnitedhealth Group
Sell
Unitedhealth Group
UNH
$284K
800 sh
$284K
Filed 04/27
Traded 04/23
David V. ElkinsEVP, CFO
SellBristol Myers Squibb
Sell
Bristol Myers Squibb
BMY
$1.6M
25,519 sh
$1.6M
Filed 04/02
Traded 04/01
Daniel Patrick O'DayChairman & CEO
Sell10b5-1 planGilead Sciences
Sell10b5-1 plan
Gilead Sciences
GILD
$1.4M
10,000 sh
$1.4M
Filed 03/30
Traded 03/27
David Ryan PurdueSVP, Controller
SellAbbVie
Sell
AbbVie
ABBV
$1.2M
5,230 sh
$1.2M
Filed 03/06
Traded 03/04
Robert J. DeckerVP Corporate Controller
SellJohnson & Johnson
Sell
Johnson & Johnson
JNJ
$1M
4,075 sh
$1M
Filed 03/03
Traded 02/27
Daniel Patrick O'DayChairman & CEO
Sell10b5-1 planGilead Sciences
Sell10b5-1 plan
Gilead Sciences
GILD
$931.9K
6,419 sh
$931.9K
Filed 03/02
Traded 02/27